T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UTAAU
2176
DELISTED
UTA Acquisition Corporation Units
UTAAU
| $739K | ﹤0.01% |
+73,500
| New | +$737K |
|
2177
TriCo Bancshares
TCBK
$1.84B
| $738K | ﹤0.01% |
17,189
-439
| -2% | -$19.3K |
|
|
TBCH
2178
Turtle Beach Corp
TBCH
$230M
| $737K | ﹤0.01% |
33,130
-7,026
| -17% | -$190K |
|
|
LAND
2179
Gladstone Land Corp
LAND
$353M
| $736K | ﹤0.01% |
21,795
-2,559
| -11% | -$68.9K |
|
2180
ATI
ATI
$31.4B
| $734K | ﹤0.01% |
46,071
-20,362
| -31% | -$327K |
|
2181
B&G Foods
BGS
$291M
| $727K | ﹤0.01% |
23,661
-2,212
| -9% | -$67.7K |
|
2182
Innoviva
INVA
$1.5B
| $727K | ﹤0.01% |
42,137
-627
| -1% | -$10.7K |
|
2183
Varex Imaging
VREX
$778M
| $726K | ﹤0.01% |
23,014
-6,400
| -22% | -$181K |
|
|
CONN
2184
DELISTED
Conn's Inc.
CONN
| $726K | ﹤0.01% |
30,849
-400
| -1% | -$9.02K |
|
2185
German American Bancorp
GABC
$1.91B
| $725K | ﹤0.01% |
18,590
+362
| +2% | +$14.5K |
|
2186
Hyliion Holdings
HYLN
$734M
| $725K | ﹤0.01% |
116,868
+65,600
| +128% | +$469K |
|
2187
Worthington Enterprises
WOR
$2.78B
| $724K | ﹤0.01% |
21,474
-2,157
| -9% | -$71K |
|
|
TVTY
2188
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $723K | ﹤0.01% |
27,360
-800
| -3% | -$20.3K |
|
2189
Xerox
XRX
$412M
| $722K | ﹤0.01% |
31,901
-44,217
| -58% | -$898K |
|
2190
Arcus Biosciences
RCUS
$3.67B
| $721K | ﹤0.01% |
17,815
-769
| -4% | -$29.8K |
|
|
SVC
2191
Service Properties Trust
SVC
$1.06B
| $721K | ﹤0.01% |
16,409
-7,636
| -32% | -$389K |
|
2192
Protolabs
PRLB
$2.17B
| $719K | ﹤0.01% |
14,009
-1,165
| -8% | -$68.7K |
|
2193
Vericel Corp
VCEL
$2.29B
| $718K | ﹤0.01% |
18,275
-3,719
| -17% | -$163K |
|
2194
Horace Mann Educators
HMN
$2.09B
| $717K | ﹤0.01% |
18,527
-736
| -4% | -$28.9K |
|
2195
Kornit Digital
KRNT
$758M
| $716K | ﹤0.01% |
+4,700
| New | +$723K |
|
|
OSG
2196
Octave Specialty Group
OSG
$210M
| $714K | ﹤0.01% |
44,474
+2,000
| +5% | +$31.4K |
|
2197
California Resources
CRC
$4.75B
| $714K | ﹤0.01% |
16,706
+9,766
| +141% | +$418K |
|
2198
Kosmos Energy
KOS
$1.51B
| $714K | ﹤0.01% |
206,395
+108,715
| +111% | +$390K |
|
2199
Senseonics Holdings Inc
SENS
$419M
| $714K | ﹤0.01% |
13,362
+2,840
| +27% | +$185K |
|
2200
Digimarc Corp
DMRC
$167M
| $713K | ﹤0.01% |
18,069
+6,795
| +60% | +$295K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.